12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
The article highlights the pre-market movements of various healthcare stocks on Tuesday. Notable gainers include Silexion Therapeutics, Adagio Medical Holdings, and Chromocell Therapeutics, while significant losers include Shattuck Labs, IGM Biosciences, and Applied DNA Sciences.
October 01, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Adagio Medical Holdings saw a 27.9% rise in its stock price during pre-market trading.
The substantial rise in ADGM's stock price indicates positive market sentiment, suggesting a potential short-term increase.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Chromocell Therapeutics' stock increased by 13.99% in pre-market trading.
The rise in CHRO's stock price suggests positive investor sentiment, likely leading to a short-term price increase.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Silexion Therapeutics shares surged by 48.6% in pre-market trading, indicating strong investor interest.
The significant increase in SLXN's stock price suggests positive sentiment or news, likely leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Applied DNA Sciences saw a 23.2% decrease in its stock price during pre-market trading.
The decline in APDN's stock price indicates negative sentiment, likely leading to a short-term price decrease.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 70
NEGATIVE IMPACT
IGM Biosciences' stock declined by 23.89% in pre-market trading.
The significant drop in IGMS's stock price suggests negative market sentiment, likely leading to a short-term price decrease.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 80
NEGATIVE IMPACT
Shattuck Labs experienced a significant 58.5% drop in its stock price during pre-market trading.
The drastic fall in STTK's stock price indicates negative sentiment or news, likely leading to a short-term price decrease.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90